186 related articles for article (PubMed ID: 15932879)
1. Mechanism of constitutive phosphoinositide 3-kinase activation by oncogenic mutants of the p85 regulatory subunit.
Shekar SC; Wu H; Fu Z; Yip SC; Nagajyothi ; Cahill SM; Girvin ME; Backer JM
J Biol Chem; 2005 Jul; 280(30):27850-5. PubMed ID: 15932879
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Class IA PI 3-kinases: C2 domain-iSH2 domain contacts inhibit p85/p110alpha and are disrupted in oncogenic p85 mutants.
Wu H; Shekar SC; Flinn RJ; El-Sibai M; Jaiswal BS; Sen KI; Janakiraman V; Seshagiri S; Gerfen GJ; Girvin ME; Backer JM
Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20258-63. PubMed ID: 19915146
[TBL] [Abstract][Full Text] [Related]
3. The iSH2 domain of PI 3-kinase is a rigid tether for p110 and not a conformational switch.
Fu Z; Aronoff-Spencer E; Wu H; Gerfen GJ; Backer JM
Arch Biochem Biophys; 2004 Dec; 432(2):244-51. PubMed ID: 15542063
[TBL] [Abstract][Full Text] [Related]
4. The structure of p85ni in class IA phosphoinositide 3-kinase exhibits interdomain disorder.
Sen KI; Wu H; Backer JM; Gerfen GJ
Biochemistry; 2010 Mar; 49(10):2159-66. PubMed ID: 20131869
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the p85/p110alpha phosphatidylinositol 3'-kinase. Distinct roles for the n-terminal and c-terminal SH2 domains.
Yu J; Wjasow C; Backer JM
J Biol Chem; 1998 Nov; 273(46):30199-203. PubMed ID: 9804776
[TBL] [Abstract][Full Text] [Related]
6. The structure of the inter-SH2 domain of class IA phosphoinositide 3-kinase determined by site-directed spin labeling EPR and homology modeling.
Fu Z; Aronoff-Spencer E; Backer JM; Gerfen GJ
Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3275-80. PubMed ID: 12629217
[TBL] [Abstract][Full Text] [Related]
7. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
[TBL] [Abstract][Full Text] [Related]
8. Phosphatidylinositol 3-kinase activation is mediated by high-affinity interactions between distinct domains within the p110 and p85 subunits.
Holt KH; Olson L; Moye-Rowley WS; Pessin JE
Mol Cell Biol; 1994 Jan; 14(1):42-9. PubMed ID: 8264609
[TBL] [Abstract][Full Text] [Related]
9. A biochemical mechanism for the oncogenic potential of the p110beta catalytic subunit of phosphoinositide 3-kinase.
Dbouk HA; Pang H; Fiser A; Backer JM
Proc Natl Acad Sci U S A; 2010 Nov; 107(46):19897-902. PubMed ID: 21030680
[TBL] [Abstract][Full Text] [Related]
10. The p85 regulatory subunit controls sequential activation of phosphoinositide 3-kinase by Tyr kinases and Ras.
Jimenez C; Hernandez C; Pimentel B; Carrera AC
J Biol Chem; 2002 Nov; 277(44):41556-62. PubMed ID: 12196526
[TBL] [Abstract][Full Text] [Related]
11. Cancer-derived mutations in the regulatory subunit p85alpha of phosphoinositide 3-kinase function through the catalytic subunit p110alpha.
Sun M; Hillmann P; Hofmann BT; Hart JR; Vogt PK
Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15547-52. PubMed ID: 20713702
[TBL] [Abstract][Full Text] [Related]
12. Synergistic activation of a family of phosphoinositide 3-kinase via G-protein coupled and tyrosine kinase-related receptors.
Katada T; Kurosu H; Okada T; Suzuki T; Tsujimoto N; Takasuga S; Kontani K; Hazeki O; Ui M
Chem Phys Lipids; 1999 Apr; 98(1-2):79-86. PubMed ID: 10358930
[TBL] [Abstract][Full Text] [Related]
13. Specific activation of p85-p110 phosphatidylinositol 3'-kinase stimulates DNA synthesis by ras- and p70 S6 kinase-dependent pathways.
McIlroy J; Chen D; Wjasow C; Michaeli T; Backer JM
Mol Cell Biol; 1997 Jan; 17(1):248-55. PubMed ID: 8972205
[TBL] [Abstract][Full Text] [Related]
14. Positive and negative roles of p85 alpha and p85 beta regulatory subunits of phosphoinositide 3-kinase in insulin signaling.
Ueki K; Fruman DA; Yballe CM; Fasshauer M; Klein J; Asano T; Cantley LC; Kahn CR
J Biol Chem; 2003 Nov; 278(48):48453-66. PubMed ID: 14504291
[TBL] [Abstract][Full Text] [Related]
15. Structure of lipid kinase p110β/p85β elucidates an unusual SH2-domain-mediated inhibitory mechanism.
Zhang X; Vadas O; Perisic O; Anderson KE; Clark J; Hawkins PT; Stephens LR; Williams RL
Mol Cell; 2011 Mar; 41(5):567-78. PubMed ID: 21362552
[TBL] [Abstract][Full Text] [Related]
16. A region of the 85-kilodalton (kDa) subunit of phosphatidylinositol 3-kinase binds the 110-kDa catalytic subunit in vivo.
Klippel A; Escobedo JA; Hu Q; Williams LT
Mol Cell Biol; 1993 Sep; 13(9):5560-6. PubMed ID: 8395006
[TBL] [Abstract][Full Text] [Related]
17. The activation of phosphatidylinositol 3-kinase by Ras.
Kodaki T; Woscholski R; Hallberg B; Rodriguez-Viciana P; Downward J; Parker PJ
Curr Biol; 1994 Sep; 4(9):798-806. PubMed ID: 7820549
[TBL] [Abstract][Full Text] [Related]
18. Dynamic steps in receptor tyrosine kinase mediated activation of class IA phosphoinositide 3-kinases (PI3K) captured by H/D exchange (HDX-MS).
Burke JE; Williams RL
Adv Biol Regul; 2013 Jan; 53(1):97-110. PubMed ID: 23194976
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine phosphorylation of p85 relieves its inhibitory activity on phosphatidylinositol 3-kinase.
Cuevas BD; Lu Y; Mao M; Zhang J; LaPushin R; Siminovitch K; Mills GB
J Biol Chem; 2001 Jul; 276(29):27455-61. PubMed ID: 11337495
[TBL] [Abstract][Full Text] [Related]
20. Expression of a mutated form of the p85alpha regulatory subunit of phosphatidylinositol 3-kinase in a Hodgkin's lymphoma-derived cell line (CO).
Jücker M; Südel K; Horn S; Sickel M; Wegner W; Fiedler W; Feldman RA
Leukemia; 2002 May; 16(5):894-901. PubMed ID: 11986952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
